Showing results (931-940 of 11,542) with videos related to
Sort By:
Pageof 1,155
British Journal of Clinical Pharmacology|August 1, 1996
Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjectsJ L Megnien, A Simon, A Andriani, et al.British Journal of Clinical Pharmacology|August 1, 1996
A cohort study of the ocular safety of anti-ulcer drugsL A García Rodríguez, S Mannino, M A Wallander, et al.British Journal of Clinical Pharmacology|August 1, 1996
The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanismsP M Bouloux, S Corsello, M Besser, et al.British Journal of Clinical Pharmacology|March 1, 1996
Caffeine as a metabolic probe: NAT2 phenotypingL J Notarianni, P Dobrocky, G Godlewski, et al.British Journal of Clinical Pharmacology|March 1, 1996
Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphismA A Somogyi, H A Reinhard, F BochnerBritish Journal of Clinical Pharmacology|March 1, 1996
Distribution and excretion of sumatriptan in human milkR E Wojnar-Horton, L P Hackett, P Yapp, et al.British Journal of Clinical Pharmacology|November 1, 1995
Cardiorespiratory effects of continuous i.v. administration of the ACE inhibitor enalaprilat in the critically illJ Boldt, M Müller, M Heesen, et al.British Journal of Clinical Pharmacology|November 1, 1995
Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-PW W Yeo, I G Chadwick, M Kraskiewicz, et al.British Journal of Clinical Pharmacology|November 1, 1995
Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteersJ Duranteau, E Pussard, A Berdeaux, et al.British Journal of Clinical Pharmacology|November 1, 1995
Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacinJ N van den Anker, W C Hop, R C Schoemaker, et al.Pageof 1,155